Human adenovirus, one of the most important viral causes of childhood respiratory illness worldwide, has been mapped in unprecedented clinical detail in a new five-year study from northern China. Drawing on more than 42,000 hospitalized children with respiratory tract infections, researchers at Hebei Children’s Hospital and Hebei Medical University have shown that two specific genotypes of the virus dominate severe pediatric disease in the region, that viral co-infections are strikingly common, and that one genotype in particular, HAdV-7, leaves a distinctive and dangerous immunological fingerprint in young patients. The findings, published in Virology Journal, offer clinicians a molecular roadmap for identifying which children are most at risk of life-threatening adenovirus pneumonia.
The retrospective study analyzed clinical data from 42,044 children admitted to Hebei Children’s Hospital between 2016 and 2020. Sputum samples collected at admission were tested for viral nucleic acids, and positive samples underwent genotyping to determine which adenovirus types were circulating. The researchers combined this molecular surveillance with demographic records, clinical symptoms, and a battery of laboratory indicators, including inflammatory markers, immune cell indices, and measures of cardiac and liver injury. Statistical comparisons relied on chi-squared tests for categorical differences and non-parametric tests, including the Mann–Whitney U and Kruskal–Wallis tests, for continuous variables, while phylogenetic relationships among viral sequences were reconstructed using the neighbor-joining method.
The headline figure is sobering: 3,123 of the 42,044 samples—7.43 percent—tested positive for human adenovirus. But the more surprising number was what came with it. Of the adenovirus-positive children, 1,954, or 62.6 percent, carried at least one additional respiratory pathogen, a phenomenon the authors call viral co-detection. Human rhinovirus was the most frequent companion, followed by respiratory syncytial virus and human parainfluenza virus. This high rate of co-infection complicates the traditional picture of adenovirus as a standalone agent of pediatric pneumonia and suggests that in many hospitalized children, adenovirus is part of a polymicrobial assault on the respiratory tract rather than a solitary invader.
Age emerged as a powerful risk factor. The highest adenovirus infection rate occurred among children aged one to three years, a finding that was statistically robust (chi-squared = 418.44, P < 0.001). This toddler window, when maternal antibodies have waned and social contact with other children is expanding, appears to represent a critical period of vulnerability. The concentration of severe cases in this age group underscores why pediatric respiratory surveillance programs that lump children together across broad age bands may obscure the populations most in need of targeted prevention.
Genotyping revealed a clear hierarchy among viral types. HAdV-3 and HAdV-7 were the predominant genotypes in both single infections and co-detections, a pattern that held up under statistical scrutiny (chi-squared = 22.227, P = 0.014). Human adenovirus is a double-stranded DNA virus with more than 100 recognized genotypes grouped into seven species, but only a handful routinely cause severe lower respiratory disease. Species B viruses, particularly types 3, 7, 14, and 55, have historically been linked to outbreaks of serious pneumonia, especially in East Asia. The Hebei data confirm that types 3 and 7 are the engines of severe pediatric disease in this region of China, consistent with surveillance reports from neighboring provinces and countries.
The most clinically consequential finding concerns HAdV-7. Children infected with this genotype were more likely to present with severe clinical manifestations, and their laboratory profiles told a coherent story of systemic disease. Levels of procalcitonin, a marker often associated with bacterial infection but elevated in severe viral inflammation, were higher in HAdV-7 cases. D-dimer, a fibrin degradation product that signals activation of coagulation, was also elevated, pointing toward the hyperinflammatory and prothrombotic state that has been described in severe adenovirus pneumonia. At the same time, the children showed depressed immune indices, suggesting that HAdV-7 may partially blunt the host response it provokes. Markers of cardiac injury and liver injury were also raised, indicating that the virus’s damage can extend well beyond the lungs.
This constellation of findings has practical implications. Procalcitonin, D-dimer, and organ injury markers are routinely measured in hospitalized children, and the study suggests that in an adenovirus-positive toddler, a rising D-dimer or abnormal liver enzymes may serve as early warning signs that the infecting genotype is a virulent strain like HAdV-7. Because adenovirus genotyping is not universally available in clinical laboratories, these surrogate laboratory signals could help clinicians escalate care, initiate antiviral therapy such as cidofovir in severe cases, or prioritize enrollment in trials of emerging adenovirus-specific treatments. There is currently no licensed adenovirus vaccine for general pediatric use outside military settings, which makes clinical risk stratification all the more important.
Phylogenetic analysis of the genotyping sequences added an international dimension to the study. The authors found that HAdV genotyping sequences exhibit high genetic similarity across different countries, meaning that the strains circulating in Hebei are close molecular relatives of those identified elsewhere. This genetic conservatism has both reassuring and concerning implications. On one hand, it suggests that vaccines or antivirals developed against these genotypes would likely remain effective across borders. On the other, it means that a virulent lineage such as HAdV-7, once it acquires enhanced transmissibility or immune escape, could spread internationally with little genetic warning, as was seen during the 2018–2019 outbreaks of HAdV-7 in China that followed the reemergence of the genotype after decades of low circulation.
The study’s five-year span, from 2016 through 2020, also captures a natural experiment in respiratory virus ecology. The final year coincides with the onset of the COVID-19 pandemic and the widespread adoption of non-pharmaceutical interventions such as masking, distancing, and school closures across China. While the present analysis focuses on genotype and clinical severity rather than temporal trends, the underlying dataset places adenovirus within a period when the entire landscape of pediatric respiratory infection was being reshaped. Understanding the baseline epidemiology of adenovirus before, during, and after such interventions will be essential for interpreting post-pandemic surges in adenovirus and other respiratory pathogens, which many countries have already observed as immunity debt and renewed social mixing collide.
For the children of Hebei Province, the message of the study is that adenovirus is not a monolithic threat. Types 3 and 7 dominate, toddlers between one and three years old are the most vulnerable, and HAdV-7 in particular signals a disease process that can involve the heart, liver, blood clotting system, and immune function simultaneously. For clinicians elsewhere, the study reinforces the value of routine molecular surveillance that goes beyond simple viral detection to genotype-level identification. In an era when sequencing is becoming cheaper and faster, the Hebei dataset provides a template for how hospitals can turn routine diagnostic samples into a public health early-warning system—identifying not just who is infected, but with what strain, and which of those strains demands the closest watch.
Subject of Research: Human adenovirus genotypes, epidemiology, and clinical severity in hospitalized children with respiratory tract infections
Subject of Research: Biology
Article Title: Molecular and clinical characterization of human adenovirus in hospitalized pediatric respiratory infections: a five-year study
Article References: Zhou, Z., Liu, L., Zhai, Y., Yan, X., Duan, S., Hong, J., Liu, T., & Yang, L. (2026). Molecular and clinical characterization of human adenovirus in hospitalized pediatric respiratory infections: a five-year study. Virology Journal. https://doi.org/10.1186/s12985-026-03266-3
Image Credits: AI Generated
DOI: 10.1186/s12985-026-03266-3
Keywords: Human adenovirus, Respiratory tract infections, HAdV-7, HAdV-3, Pediatric pneumonia, Viral co-detection, Genotyping, Epidemiology, Hospitalized children, Procalcitonin, D-dimer, Hebei Province
Cite Scienmag News
APA MLA Chicago
Kristina Jarvis. (September 4, 2026). Five-year study reveals molecular features of adenovirus in hospitalized children. Scienmag. https://scienmag.com/five-year-study-reveals-molecular-features-of-adenovirus-in-hospitalized-children/
Kristina Jarvis. “Five-year study reveals molecular features of adenovirus in hospitalized children.” Scienmag, 4 September 2026, https://scienmag.com/five-year-study-reveals-molecular-features-of-adenovirus-in-hospitalized-children/. Accessed 4 September 2026.
Kristina Jarvis. “Five-year study reveals molecular features of adenovirus in hospitalized children.” Scienmag. September 4, 2026. https://scienmag.com/five-year-study-reveals-molecular-features-of-adenovirus-in-hospitalized-children/
Copy citation Download RIS
Tags: adenovirus co-infections in hospitalized childrenadenovirus co-infections in pediatric patientsadenovirus genotyping in childrenadenovirus pneumonia risk factorschildhood respiratory illness epidemiologychildhood respiratory illness in Chinaclinical biomarkers of adenovirus infectionclinical characteristics of adenovirus infectionsgenotype-specific adenovirus pathogenicityHAdV-7 genotype immunological impactHAdV-7 immunological fingerprintlong-term study of adenovirus in Chinamolecular epidemiology of adenovirusmolecular features of adenovirus in childrenpediatric respiratory viral infectionspediatric viral infection diagnostic strategiesseverity markers of adenovirus-induced pneumoniaviral molecular surveillance in pediatricsviral nucleic acid testing in pediatricsviral surveillance in hospitalized children
